Compositions for inhibiting degradation of hyaluronic acid and methods of use thereof
AssigneeEpidarus Therapeutics, LLC
InventorDeirdre O'Sullivan
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compositions containing natural plant extracts that inhibit Hyaluronidase 1 and their use in effectively treating conditions such as dryness of skin and lips, skin damage due to UV radiation, chronic inflammatory conditions affecting the skin, the urinary bladder or prostate, osteoarthritis and joint pain, and also promoting wound healing.
Claims14
A topical composition for treating hyaluronic acid related diseases comprising a therapeutically effective amount of an extract of an Illicium species (Star Anise), an extract of a Tilia species (Linden), and an extract of a Prunella species (Prunella), wherein the composition comprises an equal amount of the extract of Star Anise, the extract of Linden and the extract of Prunella and, wherein the composition further comprises a preservative selected from benzyl alcohol-Benzyl Alcohol, dehydroacetic acid, glyceryl caprilate, potassium sorbate, caprylhydroxamic acid, caprylyl glycol, glycerin, gluconolactone and sodium benzoate, anisic acid, glyceryl caprylate and glyceryl undecylenate, ethyl lauroyl arginate, triclosan, methylisothiazolinone, methylchloroisothiazolinone, chlorphenesin, chloroxylenol, iodopropynyl butylcarbamate, methyldibromo glutaronitrile, phenoxyethanol, 2-butoxyethanol, 2-(2-butoxyethoxy)-ethanol, 2-(2-ethoxy)-ethanol, quaternium-15, sodium hydroxymethyl glycinate, methylparaben, ethylparaben, propylparaben, nutylparaben, isobutylparaben, benzoic acid, sorbic acid, or salicylic acid or any combination thereof.
Dependencies are inferred from the claim text.